Integrating rare and common variation in epilepsy genetics: from genetic architecture to penetrance and clinical expressivity
Evidence across epilepsy subtypes is reviewed, focusing on convergence and divergence across the allelic spectrum, and how polygenic background and other modifiers may influence penetrance and clinical expressivity among carriers of rare pathogenic variants and CNVs is discussed.